Godavari Drugs Limited (BOM:530317)

India flag India · Delayed Price · Currency is INR
77.27
+1.67 (2.21%)
At close: Mar 5, 2026
Market Cap581.88M -20.7%
Revenue (ttm)986.94M -22.2%
Net Income36.92M -40.0%
EPS4.91 -39.9%
Shares Out7.53M
PE Ratio15.74
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,111
Average Volume4,576
Open76.51
Previous Close75.60
Day's Range76.50 - 82.00
52-Week Range69.70 - 115.00
Beta0.17
RSI37.45
Earnings DateFeb 14, 2026

About Godavari Drugs

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs L... [Read more]

Industry Pharmaceutical Preparations
Founded 1987
Employees 106
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530317
Full Company Profile

Financial Performance

In fiscal year 2025, Godavari Drugs's revenue was 1.14 billion, a decrease of -27.42% compared to the previous year's 1.57 billion. Earnings were 43.80 million, a decrease of -21.07%.

Financial Statements